| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | C10AX13 |
| UNII: | LKC0U3A8NJ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Subtilisin/kexin type 9 inhibitor |
| Primary Target | |
|---|---|
| proprotein convertase subtilisin/kexin type 9 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperlipoproteinemia Type II | 4 | D006938 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Acute Coronary Syndrome | 3 | D054058 | ClinicalTrials |
| Hyperlipidemia, Familial Combined | 3 | D006950 | ClinicalTrials |
| Hyperlipidemias | 3 | D006949 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Heart Failure | 2 | D006333 | ClinicalTrials |
| Sepsis | 2 | D018805 | ClinicalTrials |
| ST Elevation Myocardial Infarction | 2 | D000072657 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Aortic Aneurysm, Abdominal | 1 | D017544 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1256937-27-5 |
| ChEMBL | CHEMBL2364655 |
| FDA SRS | LKC0U3A8NJ |
| Guide to Pharmacology | 7343 |
CONTENTS